Literature DB >> 30852609

The new kid on the block: suicide gene therapy to modulate cancer immunosurveillance for children with high-risk malignant brain tumors.

Sameer F Sait1, Matthias A Karajannis1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30852609      PMCID： PMC6422432          DOI： 10.1093/neuonc/noz026

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  7 in total

1.  Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma.

Authors:  Mark W Kieran; Liliana Goumnerova; Peter Manley; Susan N Chi; Karen J Marcus; Andrea G Manzanera; Maria Lucia Silva Polanco; Brian W Guzik; Estuardo Aguilar-Cordova; C Marcela Diaz-Montero; Arthur J DiPatri; Tadanori Tomita; Rishi Lulla; Lianne Greenspan; Laura K Aguilar; Stewart Goldman
Journal:  Neuro Oncol       Date:  2019-03-18       Impact factor: 12.300

Review 2.  Immunotherapy of Primary Brain Tumors: Facts and Hopes.

Authors:  Robin A Buerki; Zinal S Chheda; Hideho Okada
Journal:  Clin Cancer Res       Date:  2018-06-05       Impact factor: 12.531

Review 3.  Cytotoxic immunotherapy strategies for cancer: mechanisms and clinical development.

Authors:  Laura K Aguilar; Brian W Guzik; Estuardo Aguilar-Cordova
Journal:  J Cell Biochem       Date:  2011-08       Impact factor: 4.429

4.  Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models.

Authors:  J A Eastham; S H Chen; I Sehgal; G Yang; T L Timme; S J Hall; S L Woo; T C Thompson
Journal:  Hum Gene Ther       Date:  1996-03-01       Impact factor: 5.695

5.  The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.

Authors:  S M Freeman; C N Abboud; K A Whartenby; C H Packman; D S Koeplin; F L Moolten; G N Abraham
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

6.  Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma.

Authors:  Lee A Wheeler; Andrea G Manzanera; Susan D Bell; Robert Cavaliere; John M McGregor; John C Grecula; Herbert B Newton; Simon S Lo; Behnam Badie; Jana Portnow; Bin S Teh; Todd W Trask; David S Baskin; Pamela Z New; Laura K Aguilar; Estuardo Aguilar-Cordova; E Antonio Chiocca
Journal:  Neuro Oncol       Date:  2016-02-02       Impact factor: 12.300

Review 7.  Pediatric high-grade glioma: biologically and clinically in need of new thinking.

Authors:  Chris Jones; Matthias A Karajannis; David T W Jones; Mark W Kieran; Michelle Monje; Suzanne J Baker; Oren J Becher; Yoon-Jae Cho; Nalin Gupta; Cynthia Hawkins; Darren Hargrave; Daphne A Haas-Kogan; Nada Jabado; Xiao-Nan Li; Sabine Mueller; Theo Nicolaides; Roger J Packer; Anders I Persson; Joanna J Phillips; Erin F Simonds; James M Stafford; Yujie Tang; Stefan M Pfister; William A Weiss
Journal:  Neuro Oncol       Date:  2017-02-01       Impact factor: 12.300
  7 in total
  2 in total

1.  Need for Specialized Therapeutic Stem Cells Banks Equipped with Tumor Regression Enzymes and Anti-Tumor Genes.

Authors:  Mujib Ullah
Journal:  J Biomed Allied Res       Date:  2020-03-16

2.  Viral oncogenesis in tumours of the central nervous system: reality or random association? A retrospective study on archived material.

Authors:  Dorel Eugen Arsene; Elena Milanesi; Maria Dobre
Journal:  J Cell Mol Med       Date:  2022-02-02       Impact factor: 5.310
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.